Table 2.
Prevalence of Chronic Diseases Among Male Veterans With Multiple Sclerosis Compared With General Veteran and General Populations, United States, 2003-2004a , b
| Chronic Illness | Overall | Aged ≥50 Years | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| MS (n = 1,142) | GV (n = 31,500) | P c | GP (n = 68,357) | P d | MS (n = 962) | GV (n = 25,055) | P c | GP (n = 21,316) | P d | |
| Coronary heart disease | 10.5 | 11.5 | .30 | 3.3 | <.001 | 12.1 | 15.0 | .01 | 9.4 | .007 |
| Diabetes | 15.9 | 13.6 | .02 | 5.6 | <.001 | 17.8 | 16.7 | .37 | 14.5 | .004 |
| Hypercholesterolemia | 48.5 | 44.6 | .008 | 30.9 | <.001 | 49.7 | 48.6 | .49 | 44.8 | .002 |
| Hypertension | 46.7 | 41.2 | <.001 | 20.9 | <.001 | 49.9 | 48.1 | .26 | 42.1 | <.001 |
| Stroke | 7.0 | 4.2 | <.001 | 1.4 | <.001 | 7.9 | 5.3 | <.001 | 4.1 | <.001 |
Abbreviations: MS, veterans with multiple sclerosis; GV, general veteran population; GP, general population.
a
Unweighted total sample sizes. Data are reported as weighted percentages.
b
Item response for all variables was ≥90%.
c
Significance indicated for male veterans with MS vs men in the general veteran population; calculated using Χ2 test.
d
Significance indicated for male veterans with MS vs men in the general population; calculated using using Χ2 test.